Sunday, April 15, 2018 2:26:05 AM
MedMen reported to Captor that there has been revenue growth of 380 percent during the month of February (unaudited) at the West Hollywood location compared to February, 2017. The West Hollywood store also welcomed 22,690 visitors last month, up 345 percent compared to February, 2017.
At the Santa Ana dispensary, which opened its doors in June of 2017, MedMen reported to Captor that revenue in the month of February (unaudited) was 175 percent greater than the average monthly revenue during the period from from July to December 2017. There were 4,592 visitors at the Santa Ana store last month, up 202 percent compared to the monthly average number of visitors during the period from July to December 2017.
“Our MedMen branded dispensaries reported strong numbers and growth in the normally quiet retail month of February”, said John Zorbas, President of Captor. “We believe what we are seeing in the early months of 2018 is indicative of the potential of the recreational cannabis market in California, which for Captor is a strategic area of focus,” continued Mr. Zorbas. “
Captor acquired both cannabis dispensaries through its acquisition of all of the securities of I-5 Holdings Ltd., which closed in escrow on February 23, 2018. The closing remains ins escrow pending the satisfaction of certain conditions precedent.
About Captor Capital
Captor Capital Corp. is a Canadian investment firm listed on the Canadian Securities Exchange and the Frankfurt Stock Exchange. The company follows a strategy of acquiring profitable, established companies and organizations with growth potential that require capital to scale. Captor currently has investments in a number of companies and industries, including Millennial Esports in the technology sector, I-5 Holdings in the cannabis sector, and URU Metals in the natural resources sector.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM